How to Hire a Biostatistics Consulting Firm: What to Evaluate
What a biostatistics or regulatory affairs consultancy actually delivers, what to verify in a statistician's track record, and the RFP questions that separate real submission experience from a generic capabilities deck.
A biostatistics consulting firm designs a clinical trial's statistical analysis plan, determines sample size, runs interim and final analyses, and prepares the statistical sections of regulatory submissions. Many also offer regulatory affairs strategy. Buyers should verify named statisticians' direct FDA/EMA submission experience, not just firm-level credentials, before engaging.
Real US search demand (Ahrefs): ~80 searches/mo for "biostatistics consulting" · ~$4.50 CPC.
The buyer problem
Statistical and regulatory strategy mistakes are expensive to discover late: an underpowered trial, a Data Monitoring Committee firewall breach, or a submission package an agency kicks back for methodology. Firm-level marketing rarely tells a sponsor whether the specific statisticians on their program have actually taken a comparable design through a real FDA or EMA submission.
What a how to hire a biostatistics consulting firm: what to evaluate vendor does
A biostatistics consultancy designs the statistical analysis plan (SAP) for a trial, calculates sample size and power, supports adaptive or Bayesian trial designs, runs interim analyses and supports Data Monitoring Committees, and prepares the statistical sections of regulatory submission packages. Firms in this space frequently also offer regulatory affairs consulting: strategy for agency meetings, submission planning, and pharmacovigilance or CMC/quality compliance advisory work, often blending the two disciplines under one roof.
Methods and techniques
- Statistical analysis plan (SAP) development
- Sample size and power calculations
- Adaptive and Bayesian trial design
- Interim analysis and Data Monitoring Committee support
- Regulatory statistical submission packages (FDA/EMA)
- Regulatory strategy and agency-meeting preparation
What to verify before you retain
- Named statistician's submission history. Ask for the specific statisticians who will work on your program and their direct experience preparing statistical sections for FDA or EMA submissions, not the firm's aggregate case count.
- Therapeutic-area and trial-design fit. Confirm direct experience with your trial design type (adaptive, Bayesian, non-inferiority, etc.) and therapeutic area, since statistical approaches vary significantly by both.
- Software and validation practices. Ask which statistical software (SAS, R) the firm uses and how it validates programming output against regulatory expectations.
- Regulatory agency interaction experience. If you need regulatory strategy support, ask for examples of agency meetings (Type B/C, pre-IND) the consultant has directly supported.
- Data security and confidentiality practices. Confirm how the firm handles unblinded interim data and what safeguards separate DMC-facing statisticians from the sponsor-facing team.
Questions to put in your RFP
- Which named statisticians will work directly on our program, and what is their FDA/EMA submission history?
- What is your direct experience with our specific trial design (adaptive, Bayesian, group-sequential, etc.)?
- What statistical software do you use, and what is your programming validation process?
- If we need Data Monitoring Committee support, how do you firewall unblinded data from the sponsor-facing team?
- Can you provide examples of regulatory agency meetings you've directly supported in our therapeutic area?
- What is your typical turnaround for a statistical analysis plan or a submission-ready analysis package?
Skip the cold search. Send this scope to us and we route it toward qualified regulatory & biostatistics vendors.
Request vendorsRed flags
- Cannot name the specific statisticians who will do the work, only firm-level credentials.
- Vague about direct FDA/EMA submission experience versus general biostatistics background.
- No clear process for firewalling unblinded interim data from the sponsor team.
- Unfamiliar with your specific trial design type when asked for direct examples.
- Resistance to naming software validation or quality-control practices.
Standards and governing bodies
Bodies referenced in this category. Listed for context; they do not endorse this index or any vendor. Verify any credential directly with the issuing body.
- FDA
- U.S. Food and Drug Administration. Reviews statistical analysis plans and submission packages as part of IND, NDA, and BLA review.
- ICH E9
- International Council for Harmonisation E9. The internationally harmonized guideline on statistical principles for clinical trials that most regulatory-grade statistical work is built against.
- EMA
- European Medicines Agency. Reviews statistical methodology as part of clinical trial and marketing authorization applications in the EU.
Notable how to hire a biostatistics consulting firm: what to evaluate vendors
Real, publicly-documented vendors active in this category. Sourced and verified; not a ranking or endorsement.
How to Hire a Biostatistics Consulting Firm: What to Evaluate: buyer FAQ
What is the difference between a biostatistics consultancy and a full-service CRO's in-house biostatistics team?
An independent biostatistics consultancy specializes solely in statistical design, analysis, and regulatory statistical writing, often for sponsors who want statistical independence from their operational CRO or who need specialized expertise a generalist CRO's in-house team may not have. A CRO's in-house biostatistics group is bundled into a broader operational contract.
Do we need a biostatistics consultant if our CRO already has a biostatistics team?
Not always. Many sponsors use their CRO's in-house biostatisticians for standard designs and only bring in an independent consultant for complex adaptive designs, second-opinion review, or genuine statistical independence for a Data Monitoring Committee.
How is regulatory affairs different from biostatistics consulting?
Regulatory affairs consulting focuses on agency strategy, submission planning, and interactions with regulators like the FDA or EMA. Biostatistics consulting focuses on trial design and data analysis. Some firms offer both under one roof; others specialize in just one.